Tylenol and ibuprofen are discussed as acceptable options for symptom relief, though their long-term effects remain uncertain. The conversation delves into the complexities of contagion, emphasizing the unknowns surrounding infection rates and fatality statistics. With a focus on realism, the dialogue highlights the challenges in determining true infection numbers and the implications of reported death rates.
